White House pharmacy under the microscope
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Category: policy
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
The White House has a pharmacy — and it’s been a mess, a new investigation found
There’s a pharmacy in the White House — or, at least, there’s a sign that…
Medicare Advantage update pushes Wall Street to reset expectations
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: FDA sets aggressive deadline for inspection overhaul
WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul…
STAT+: Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the…
STAT+: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension
WASHINGTON — Negotiations to add extra health care policies to Congress’ stopgap funding bill fell…
STAT+: Biden changes will force health insurers to speed up and get more specific if they want to deny care
The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying…
The big any-day-now biotech news we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The state of Medicare Advantage, in one chart
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Health care negotiations on Capitol Hill are clear as mud
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
The four biotech stories you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: The new NIH director is walking a tightrope on Biden’s drug pricing vision
WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally…
.jpg)
STAT+: Could private equity be the future of private practice? A new lobbying group thinks so
Private equity gets a bad rap in health care. But some doctors see that kind…
STAT+: Fiery MedPAC meeting highlights massive overpayments in Medicare Advantage
Medicare Advantage is arguably the most controversial health care program right now — a sentiment…
STAT+: Courts will decide the future of Medicare’s power to negotiate drug prices within months
WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare…
After grilling Fauci on Covid origins, House Republicans want to consider new rules for foreign research
WASHINGTON — House Republicans want to explore tighter inspection and safety requirements for infectious disease…
STAT+: Heated lawsuit between AdventHealth, MultiPlan attracts hospital lobbyists
A lawsuit between a large hospital system and a dominant vendor that works for health…
Anthony Fauci talked Covid in Congress in a nine-hour, closed-door grilling — and that was just day one
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy
WASHINGTON — He’s been called the “invisible” secretary. So far removed from the White House…
STAT+: CVS Health sees Medicare Advantage patients seek more care, eating into profits
Medicare Advantage members continue to go to the doctor and get health care procedures a…
STAT+: Sen. Sanders, others lawmakers open probe into asthma inhaler makers over pricing, patent maneuvers
Several U.S. lawmakers including Sen. Bernie Sanders (I-Vt.) are investigating the prices charged by four…
STAT+: HHS names inaugural chief competition officer
The Department of Health and Human Services will name Stacy Sanders as its new chief…
STAT+: What to expect from hospitals and health insurers at this year’s JPM Healthcare Conference
Nonprofit hospitals often get overshadowed at the J.P. Morgan Healthcare Conference, the health care industry’s…
Biden’s FDA is letting Ron DeSantis import cheaper drugs from Canada. Who gets to take credit?
WASHINGTON — The Biden administration has approved Florida Gov. Ron DeSantis’ plan to import a…
At JPM, how much health policy talk should we expect?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Another major pharma company departs BIO
WASHINGTON — UCB left BIO at the end of 2023, the second major member company to…
UnitedHealth’s rehab restrictions, Texas medical school drama, and health care’s biggest profits
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of…
An ugly fight over care for the poor in Texas
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Here’s who’s profiting the most in health care
For all the flack they get, the country’s four biggest pharmacy benefit managers reported a…
STAT+: 3 FDA staffers to watch in 2024
WASHINGTON — The Food and Drug Administration has a lot on its plate in 2024…
STAT+: Venture capital is still pouring into drug research despite Medicare price negotiation
WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s…
STAT+: AAFP’s CEO on how to keep primary care doctors in the field
In ten years, the United States could be short as many as 48,000 primary care…
STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny
WASHINGTON — Medical marijuana companies sell medicine, just like pharmaceutical companies. But they’re not playing…
STAT+: Drugs are still mostly tested in white men. Will the FDA change that next year?
WASHINGTON — Sometime next year drug and medical device companies will have to tell the…
Pregnant cancer patients often have to terminate. Abortion pill restrictions could make that choice even harder
WASHINGTON — The patient had already made the agonizing decision to start chemotherapy to address…
STAT+: In the U.S., scientists see barriers to the development of CAR-T therapies. In Spain, a hospital brews its own
BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital…
What the new health counsels at FTC, DOJ, and HHS might do
Three major government agencies are adding new officials to investigate price-gouging in health care —…
STAT+: Biden administration asks judge to toss out Humana’s Medicare Advantage audit lawsuit
The Department of Justice has asked a federal judge to dismiss a lawsuit brought by…
Tome Biosciences goes public today in another biotech megaround
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Methadone clinics spar with addiction doctors on bill that would widen access
Lawmakers on Tuesday will debate an addiction medicine proposal that would have been considered unthinkable…
House passes site-neutral policy, transparency, PBM reform package
WASHINGTON — The House passed a relatively major health care package late Monday, an end-of-year…
STAT+: UnitedHealth executive to head health insurance group AHIP
WASHINGTON — An executive at insurance giant UnitedHealth Group is slated to be the next…
STAT+: Hot antitrust environment hangs over called-off merger between Cigna and Humana
Less than two weeks after reports surfaced saying Cigna and Humana were considering combining into…
Morning Rounds: Preterm birth rates vary across the U.S., with the highest in the Southeast
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Morning Rounds: 3D-printed organs, antimicrobial resistance in Ukraine, and other major health stories of the day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT+: Sen. Warren pushes for more data on Medicare Advantage coverage hurdles, denials
A bipartisan group of senators is urging the Biden administration to beef up the amount…
STAT+: Biden proposal targeting pharma patents spurs industry fears and consumer doubts
Will this be a half a loaf? After months of deliberation, the Biden administration on…
Diabetes ‘epidemic’ gets a Senate hearing
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: To lower drug prices, White House takes new aim at pharma patents
WASHINGTON — The White House is throwing its support behind a controversial authority that allows…